检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]青海大学附属医院老年科,青海西宁
出 处:《外科(汉斯)》2019年第3期78-83,共6页Hans Journal of Surgery
摘 要:糖尿病已成为一个全球性的严重公共卫生问题,随着生活方式的改变和老龄化等多种因素驱动下,我国糖尿病患病率呈逐年递增趋势,2017年中国糖尿病患病率为10.9%估算糖尿病患者数量1.14亿,位居世界第一,糖尿病肾病是糖尿病最常见的并发症之一,是导致终末期肾脏病(ESRD)的主要病因,一旦患者进展至ESRD,需要接受肾脏替代治疗,严重影响患者的生活质量,给家庭带来严重的经济负担,因此糖尿病肾病治疗的研究已经成为一个非常严峻问题,但是目前对糖尿病肾病缺乏有效的治疗方法,本文总结了目前我国部分糖尿病肾病治疗的研究进展,为临床治疗及后续研究提供参考。Diabetes mellitus has become a serious global public health problem.Driven by lifestyle changes and aging,the prevalence of diabetes in China is increasing year by year.In 2017,the prevalence of diabetes mellitus in China is 10.9%.The estimated number of diabetic patients is 114 million,ranking first in the world.Diabetic nephropathy is one of the most common complications of dia-betes mellitus,and it is the end-stage kidney.The main etiology of diabetic nephropathy(ESRD)is that once patients progress to ESRD,they need renal replacement therapy,which seriously affects the quality of life of patients and brings serious financial burden to their families.Therefore,the research of diabetic nephropathy treatment has become a very serious problem,but there is no effective treatment for diabetic nephropathy at present.This paper summarizes some diabetic nephropathy in China.The research progress of disease treatment can provide reference for clinical treatment and follow-up research.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15